TIDMACRL

RNS Number : 4773V

Accrol Group Holdings PLC

10 August 2022

10 August 2022

ACCROL GROUP HOLDINGS PLC

("Accrol" or the "Group")

AIM: ACRL

Notice of Final Results and Online Presentations

Accrol, the UK's leading independent tissue converter, announces that it will release its Final Results for the year ended 30 April 2022 on Tuesday, 6 September 2022.

An analyst briefing will be held online at 9.00 am on that day. Equity analysts interested in joining the meeting should contact Belvedere Communications.

As part of the Group's Results roadshow, the management will host an online investor presentation and Q&A session. This will take place on Wednesday, 7 September 2022 at 12.30pm. Anyone wishing to participate should register for the event with PI World at: https://bit.ly/ACRL_FY22.

For further information, please contact:

 
 Accrol Group Holdings plc                  Via Belvedere Communications 
  Dan Wright, Executive Chairman 
  Gareth Jenkins, Chief Executive Officer 
  Richard Newman, Chief Financial Officer 
 Zeus (Nominated Adviser & Broker) 
  Dan Bate / Jordan Warburton (Investment           Tel: +44 (0) 161 831 
  Banking)                                                          1512 
  Dominic King (Corporate Broking)                  Tel: +44 (0) 203 829 
                                                                    5000 
 Liberum Capital Limited (Joint Broker) 
  Clayton Bush / Edward Thomas                      Tel: +44 (0) 20 3100 
                                                                    2222 
 Belvedere Communications Limited 
  Cat Valentine                                    Tel: +44 (0) 7715 769 
  Keeley Clarke                                                      078 
                                                   Tel: +44 (0) 7967 816 
                                                                     525 
                                                accrolpr@belvederepr.com

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the GBP2.1bn UK retail tissue market.

For more information, please visit www.accrol.co.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORDGGDIRBGDGDC

(END) Dow Jones Newswires

August 10, 2022 02:00 ET (06:00 GMT)

Accrol (LSE:ACRL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Accrol Charts.
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Accrol Charts.